GlassScriptPhysician profile
Shelly Gupta
NPI 1831558329
$21,707.76
in general payments reported to CMS, 2019-2025
92 companies · $5,264 in 2025
The $5,264 reported for 2025 was more than what 83% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $166 · 2021: $875 · 2022: $4,424 · 2023: $4,572 · 2024: $5,337 · 2025: $5,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,051.19 |
| Education | $120.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,542.64 | 2019-2025 | Enhertu, Imfinzi, Calquence |
| Pfizer INC. | $1,414.32 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,247.19 | 2019-2025 | Opdivo, Pomalyst |
| Janssen Biotech, INC. | $1,156.43 | 2022-2025 | Rybrevant, Darzalex, Carvykti |
| Merck Sharp & Dohme LLC | $1,121.75 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $982.35 | 2022-2025 | |
| Celgene Corporation | $976.24 | 2020-2025 | Reblozyl, Opdualag, Pomalyst |
| Takeda Pharmaceuticals U.S.A., INC. | $869.73 | 2019-2025 | Ninlaro, Iclusig, Fruzaqla |
| Glaxosmithkline, LLC. | $665.04 | 2021-2025 | Jemperli, Zejula, Ojjaara |
| Amgen INC. | $641.03 | 2019-2025 | Kyprolis, Lumakras, Blincyto |
| Gilead Sciences, INC. | $507.33 | 2021-2025 | Trodelvy |
| Astellas Pharma US INC | $479.32 | 2021-2025 | Padcev, Xospata, Xtandi |
| Genzyme Corporation | $438.23 | 2019-2025 | |
| Eisai INC. | $435.57 | 2020-2025 | |
| Incyte Corporation | $410.01 | 2019-2025 | Monjuvi, Monjuvi, Jakafi |
Show all 92 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $395.05 | 2022-2025 | Enhertu, Datroway |
| Alexion Pharmaceuticals, INC. | $339.14 | 2019-2025 | Ultomiris |
| Lilly USA, LLC | $337.94 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Exelixis INC. | $326.20 | 2019-2025 | Cabometyx |
| Pharmacyclics LLC, An Abbvie Company | $301.67 | 2019-2023 | Imbruvica, Epkinly |
| Seagen INC. | $295.10 | 2022-2023 | Tukysa, Adcetris |
| Abbvie INC. | $288.24 | 2024-2025 | |
| Genentech USA, INC. | $279.35 | 2019-2025 | Venclexta, Tecentriq, Phesgo |
| Sobi, INC | $238.22 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $220.93 | 2024-2025 | |
| Beigene USA, INC. | $216.84 | 2021-2024 | Brukinsa |
| Puma Biotechnology, INC. | $205.79 | 2022-2024 | |
| Taiho Oncology, INC. | $188.77 | 2021-2024 | |
| Pharmacosmos Therapeutics INC. | $184.14 | 2023-2025 | Monoferric |
| Regeneron Healthcare Solutions, INC. | $182.35 | 2019-2025 | Libtayo, Lynozyfic |
| Emd Serono, INC. | $180.14 | 2021-2025 | Tepmetko |
| Stemline Therapeutics INC. | $178.50 | 2020-2025 | Orserdu |
| Octapharma USA, INC. | $172.09 | 2023-2025 | Octagam Immune Globulin (Human), Panzyga |
| Array Biopharma INC | $168.11 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Aveo Pharmaceuticals, INC. | $157.06 | 2022-2025 | |
| Kite Pharma, INC. | $148.80 | 2022-2025 | Yescarta |
| Pharmaessentia USA Corporation | $142.03 | 2022-2025 | Besremi |
| Blueprint Medicines Corporation | $140.17 | 2023-2025 | Ayvakit |
| Sanofi-Aventis U.S. LLC | $137.36 | 2019-2022 | |
| Organon LLC | $131.52 | 2023-2025 | Ontruzant |
| Myriad Genetic Laboratories, INC. | $129.50 | 2023 | Precisetumor, Myrisk |
| Syndax Pharmaceuticals, INC. | $127.74 | 2025 | |
| US Oncology Corporate, INC. | $126.47 | 2024 | |
| Progenics Pharmaceuticals, INC. | $125.00 | 2024 | |
| Geron Corporation | $118.27 | 2024-2025 | Rytelo |
| Conmed Corporation | $117.08 | 2022 | |
| Tactile Systems Technology INC | $114.00 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.05 | 2024-2025 | Gilotrif |
| Agios Pharmaceuticals, INC. | $111.53 | 2024-2025 | Pyrukynd |
| Acera Surgical, INC. | $111.11 | 2024 | Restrata Wound Matrix |
| Rigel Pharmaceuticals, INC. | $110.43 | 2022-2024 | Rezlidhia, Tavalisse |
| Adc Therapeutics America, INC. | $102.76 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.57 | 2024-2025 | |
| Servier Pharmaceuticals LLC | $101.27 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $90.70 | 2022 | |
| Dexcom, INC. | $83.82 | 2022-2024 | Dexcom G6 Transmitter |
| Beone Medicines USA, INC. | $77.61 | 2025 | Brukinsa |
| Springworks Therapeutics, INC. | $76.16 | 2024-2025 | Ogsiveo |
| Cti Biopharma Corp. | $72.11 | 2022-2023 | Vonjo |
| Tempus Ai, INC | $70.18 | 2025 | Xt Cdx |
| Avanos Medical | $69.21 | 2023 | On-Q* Pump and Accessories |
| Clovis Oncology, INC. | $68.89 | 2021-2022 | |
| Tersera Therapeutics LLC | $68.39 | 2021-2024 | Zoladex |
| Coherus Oncology, INC. | $67.36 | 2024-2025 | Loqtorzi |
| Morphosys, US INC. | $66.24 | 2022-2024 | Monjuvi |
| Immunocore Limited | $65.53 | 2022-2025 | Kimmtrak |
| Iovance Biotherapeutics, INC. | $60.32 | 2025 | Amtagvi |
| Myovant Sciences INC. | $57.57 | 2021-2022 | |
| Ethicon US, LLC | $46.83 | 2022 | |
| Deciphera Pharmaceuticals INC. | $46.66 | 2023-2024 | Qinlock |
| Mirati Therapeutics, INC. | $46.35 | 2023 | Krazati |
| Acrotech Biopharma INC. | $42.77 | 2021-2025 | Beleodaq |
| Fennec Pharmaceuticals, INC. | $40.08 | 2024-2025 | Fyarro, Pedmark |
| Novocure INC. | $37.90 | 2024-2025 | Optune, Optune Lua (Novottf-200t) |
| Karyopharm Therapeutics INC. | $34.25 | 2024 | Xpovio |
| Biocon Biologics INC | $28.87 | 2024 | Fulphila |
| Kyowa Kirin, INC. | $27.54 | 2025 | |
| Biomarin Pharmaceutical INC. | $26.81 | 2024 | Roctavian |
| Sumitomo Pharma America, INC. | $24.34 | 2024 | Orgovyx |
| Sun Pharmaceutical Industries INC. | $23.13 | 2024 | |
| Intuitive Surgical, INC. | $22.73 | 2024 | |
| Foundation Medicine, INC. | $22.70 | 2023 | |
| Epizyme, INC. | $20.22 | 2021 | |
| Cardinal Health 414 LLC | $20.13 | 2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| G1 Therapeutics, INC. | $19.61 | 2022 | |
| Amag Pharmaceuticals, INC. | $19.37 | 2021 | |
| Global Blood Therapeutics, INC. | $19.17 | 2022 | |
| Novo Nordisk INC | $19.03 | 2023 | Ozempic, Rybelsus |
| Azurity Pharmaceuticals, INC. | $18.98 | 2025 | Danziten |
| Legend Biotech USA INC. | $18.74 | 2025 | Carvykti |
| Fresenius Kabi USA, LLC | $18.55 | 2025 | Stimufend |
| Insulet Corporation | $16.44 | 2022 |
Drugs and devices associated with these payments
Keytruda $925Opdivo $653Reblozyl $609Enhertu $598Imbruvica $513Tukysa $478Jemperli $401Zejula $371Ibrance $357Xtandi $319Imfinzi $277Calquence $276Epkinly $265Rybrevant $255Padcev $250Monjuvi $242Lynparza $239Cabometyx $237Darzalex $226Trodelvy $217Lenvima $215Brukinsa $208Ninlaro $207Scemblix $189Monoferric $184Pomalyst $178Sarclisa $175Oxbryta $168Zepzelca $153Tagrisso $153Iclusig $151Fruzaqla $151Inlyta $150Pluvicto $148Carvykti $147Adcetris $142Ayvakit $140Orserdu $139Verzenio $138Octagam Immune Globulin (Human) $138Braftovi $136Mektovi $136Ontruzant $132Ultomiris $127Talzenna $126Venclexta $125Pylarify $125Jaypirca $125Rytelo $118Kisqali $117Elrexfio $117Lutathera $115Libtayo $114Restrata Wound Matrix $111Fotivda $109Xospata $102Lorbrena $95.26Lonsurf $89.89Inqovi $89.89Pyrukynd $88.29Bosulif $85.90Vonjo $85.32Opdualag $80.43Vpriv $79.83Besremi $78.67Mekinist $78.05Ogsiveo $76.16Nubeqa $76.10Precisetumor $75.75Comirnaty $73.25Xt Cdx $70.18On-Q* Pump and Accessories $69.21Rezlidhia $69.06Tavalisse $69.06Ziihera $68.18Flexitouch Plus $67.97Kyprolis $66.54Tecentriq $63.62Jevtana $62.97Orgovyx $62.57Amtagvi $60.32Promacta $60.22Lumakras $59.31Fabhalta $55.05Welireg $54.30Xalkori $53.97Myrisk $53.75Enjaymo $53.42Cablivi $53.42Paxlovid $50.18Stivarga $47.60Retevmo $47.00Zoladex $46.72Qinlock $46.66Tasigna $46.66Krazati $46.35Blincyto $45.67Tibsovo $44.64Tecvayli $44.56Nimbl $41.88
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelly Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.